Sarah Alonzi1, Michael Hoerger2,3, Laura M Perry4, Lydia D Chow5, Charlotte Manogue6, Patrick Cotogno6, Emma M Ernst7, Elisa M Ledet6, Oliver Sartor8. 1. Department of Psychology, Loyola University New Orleans, New Orleans, LA, 70118, USA. 2. Departments of Psychology, Psychiatry, and Medicine (Oncology), and Tulane Cancer Center, Tulane University, 6400 Freret Street, 2007 Percival Stern Hall, New Orleans, LA, 70118, USA. mhoerger@tulane.edu. 3. Department of Palliative Medicine & Supportive Care, University Medical Center of New Orleans, New Orleans, LA, 70112, USA. mhoerger@tulane.edu. 4. Department of Psychology, Tulane University, New Orleans, LA, 70118, USA. 5. Department of Internal Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, 90033, USA. 6. Tulane Cancer Center, Tulane University, New Orleans, LA, 70112, USA. 7. Tufts University School of Medicine, 145 Harrison Ave, Boston, MA, 02111, USA. 8. Departments of Medicine and Urology, and Tulane Cancer Center, Tulane University, New Orleans, LA, 70112, USA.
Abstract
PURPOSE: The present study examined the prevalence of changes in the taste and smell of food among men with advanced prostate cancer who were receiving hormone therapy and/or chemotherapy. METHOD: Participants were 75 men with advanced prostate cancer treated at an academic medical center. They completed a prospective survey about nausea while eating, taste and smell of food, and appetite periodically during a mean of 1.3 years of follow-up. Demographics, treatments, and weight data were extracted from electronic health records. Logistic regression analyses were used to examine the associations between the presence of the symptoms surveyed, treatments, and weight loss of ≥10%. RESULTS: Participants experienced poor taste of food (17%) and poor smell of food (8%) during the study. Nausea was associated with an increased likelihood of experiencing poor taste (50.0% v 12.3%, OR=7.13, P=.008) and smell (30.0% v 4.6%, OR=8.86, P=.016) of food. Poor taste of food was associated with an increased likelihood of experiencing poor appetite (35.0% v 10.9%, OR=12.43, P<.001). Participants were more likely to experience poor taste of food at any point in the study if they were being treated with denosumab (35.0% v 10.9%, OR=4.40, P=.020) or docetaxel (41.7% v 12.7%, OR=4.91, P=.022). Participants were more likely to experience ≥10% weight loss if experiencing poor taste of food (38.4% v 8.6%, OR=6.63, P=.010) or poor appetite (60.0% v 6.6%, OR=21.38, P<.001). CONCLUSION: Clinicians should query patients for changes in taste and smell of food, especially if they are experiencing weight loss.
PURPOSE: The present study examined the prevalence of changes in the taste and smell of food among men with advanced prostate cancer who were receiving hormone therapy and/or chemotherapy. METHOD: Participants were 75 men with advanced prostate cancer treated at an academic medical center. They completed a prospective survey about nausea while eating, taste and smell of food, and appetite periodically during a mean of 1.3 years of follow-up. Demographics, treatments, and weight data were extracted from electronic health records. Logistic regression analyses were used to examine the associations between the presence of the symptoms surveyed, treatments, and weight loss of ≥10%. RESULTS: Participants experienced poor taste of food (17%) and poor smell of food (8%) during the study. Nausea was associated with an increased likelihood of experiencing poor taste (50.0% v 12.3%, OR=7.13, P=.008) and smell (30.0% v 4.6%, OR=8.86, P=.016) of food. Poor taste of food was associated with an increased likelihood of experiencing poor appetite (35.0% v 10.9%, OR=12.43, P<.001). Participants were more likely to experience poor taste of food at any point in the study if they were being treated with denosumab (35.0% v 10.9%, OR=4.40, P=.020) or docetaxel (41.7% v 12.7%, OR=4.91, P=.022). Participants were more likely to experience ≥10% weight loss if experiencing poor taste of food (38.4% v 8.6%, OR=6.63, P=.010) or poor appetite (60.0% v 6.6%, OR=21.38, P<.001). CONCLUSION: Clinicians should query patients for changes in taste and smell of food, especially if they are experiencing weight loss.
Entities:
Keywords:
Dysgeusia; Dysosmia; Prostate cancer; Weight loss
Authors: Honor A Blackwood; Charlie C Hall; Trude R Balstad; Tora S Solheim; Marie Fallon; Erna Haraldsdottir; Barry J Laird Journal: Support Care Cancer Date: 2019-07-29 Impact factor: 3.603
Authors: Jae Hee Hong; Pinar Omur-Ozbek; Brian T Stanek; Andrea M Dietrich; Susan E Duncan; Yong Woo Lee; Glenn Lesser Journal: J Support Oncol Date: 2009 Mar-Apr
Authors: Michael Hoerger; Joseph A Greer; Vicki A Jackson; Elyse R Park; William F Pirl; Areej El-Jawahri; Emily R Gallagher; Teresa Hagan; Juliet Jacobsen; Laura M Perry; Jennifer S Temel Journal: J Clin Oncol Date: 2018-02-23 Impact factor: 44.544
Authors: L E Spotten; C A Corish; C M Lorton; P M Ui Dhuibhir; N C O'Donoghue; B O'Connor; T D Walsh Journal: Ann Oncol Date: 2017-05-01 Impact factor: 32.976
Authors: Kisha I Coa; Joel B Epstein; David Ettinger; Aminah Jatoi; Kathy McManus; Mary E Platek; Wendy Price; Meghan Stewart; Theodoros N Teknos; Bruce Moskowitz Journal: Nutr Cancer Date: 2015-02-09 Impact factor: 2.900